Cardiff Oncology Inc (CRDF)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -67.988 | -88.667 | -124.617 | -122.58 | -30.575 | -19.921 | -29.148 | -41.92 |
Return on Equity (%) | -114.586 | -189.777 | -198.734 | -192.09 | -33.361 | -21.085 | -31.389 | -47.097 |
Return on Invested Capital (%) | -86.949 | -131.098 | -211.878 | -194.677 | -28.294 | -21.539 | -32.555 | -52.373 |
Operating Margin (%) | -9928.871 | -4727.327 | -4348.148 | -6699.592 | -5274.317 | -7880.501 | -10026.943 | -8492.008 |
Net Profit Margin (%) | -10296.063 | -4936.832 | -4361.111 | -6819.184 | -6174.044 | -7887.187 | -10033.161 | -8496.926 |
Book Value Per Share | 0.643 | 0.123 | 2.59 | 0.845 | 3.479 | 3.346 | 2.454 | 1.559 |
Earnings Per Share | -1.275 | -0.472 | -4.235 | -1.93 | -0.613 | -0.675 | -0.894 | -0.927 |
Cash Per Share | 0.452 | 0.156 | 2.942 | 1.178 | 3.555 | 0.285 | 0.377 | 0.484 |
Working Capital Per Share | 1.013 | 0.104 | 2.517 | 0.759 | 3.454 | 3.326 | 2.388 | 1.497 |
Operating Profit Per Share | -0.044 | -0.003 | -0.056 | 0.028 | 0.01 | 0.009 | 0.009 | 0.011 |
EBIT Per Share | -1.275 | -0.471 | -4.228 | -1.896 | -0.524 | -0.674 | -0.893 | -0.926 |
EBITDA Per Share | -1.275 | -0.471 | -4.228 | -1.896 | -0.524 | -0.674 | -0.893 | -0.926 |
Free Cash Flow Per Share | -1.283 | -0.49 | -4.422 | -1.98 | -0.62 | -0.681 | -0.881 | -0.923 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 30,7M | 52,79M | 3,83M | 8,59M | 36,78M | 41,96M | N/A | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | 44,68M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -13521.687 | N/A | N/A | N/A | -4883.415 | N/A | N/A |
Net Profit Margin (%) | N/A | -13528.916 | N/A | N/A | N/A | -4886.341 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 240,33M |
Ratio cours/bénéfice | -1,47 |
Ratio prix/ventes | 125,26 |
Ratio prix/liquidités | 2,81 |
Ratio prix/valeur comptable | 0,87 |
Rendement de dividende | - |
Actions en circulation | 51,13M |
Volume moyen (1 semaine) | 1,21M |
Volume moyen (1 mois) | 4,88M |
Variation sur 52 semaines | 191,14% |
Plus haut sur 52 semaines | 6,42 |
Plus bas sur 52 semaines | 1,44 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales